Prognostic significance and immunological role of HPRT1 in human cancers

Hypoxanthine phosphoribosyl transferase 1 (HPRT1), once considered a housekeeping gene, has been identified as playing an important role in several tumors. Its role in pan-cancer, however, has not been systematically studied. This study evaluates the relationship between HPRT1 and clinical paramete...

Full description

Bibliographic Details
Main Authors: Yiwen Lu, Ruixue Chen, Han Zhang, Xu Sun, Xiangjun Li, Mengyuan Yang, Xudong Zhang
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2024-03-01
Series:Biomolecules & Biomedicine
Subjects:
Online Access:https://www.bjbms.org/ojs/index.php/bjbms/article/view/9775
_version_ 1797261383582089216
author Yiwen Lu
Ruixue Chen
Han Zhang
Xu Sun
Xiangjun Li
Mengyuan Yang
Xudong Zhang
author_facet Yiwen Lu
Ruixue Chen
Han Zhang
Xu Sun
Xiangjun Li
Mengyuan Yang
Xudong Zhang
author_sort Yiwen Lu
collection DOAJ
description Hypoxanthine phosphoribosyl transferase 1 (HPRT1), once considered a housekeeping gene, has been identified as playing an important role in several tumors. Its role in pan-cancer, however, has not been systematically studied. This study evaluates the relationship between HPRT1 and clinical parameters, survival prognosis, and tumor immunity based on multi omics data from the Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) databases. Drug sensitivity analysis screened 16 effective drugs against HPRT1, exploring the interactions with chemicals and genes. The significance of HPRT1 in tumor immunotherapy has also been investigated. Immunohistochemistry confirmed significant differences in the expression of HPRT1 between five tumor types (colon adenocarcinoma [COAD], head-neck squamous cell carcinoma [HNSC], lung adenocarcinoma [LUAD], thyroid carcinoma [THCA], and uterine corpus endometrial carcinoma [UCEC]) and adjacent normal tissues (P < 0.05). HPRT1 competitive endogenous RNA network was constructed in HNSC. Through cytological experiments, it was verified that HPRT1 plays a carcinogenic role in HNSC and is associated with tumor cell proliferation, migration, invasion, and apoptosis. In addition, there was a significant positive correlation between HPRT1 and programmed cell death-1 (PD-1) expression in HNSC (P < 0.05). These findings suggest that HPRT1 may be a potential biomarker for predicting and treating cancer.
first_indexed 2024-04-24T23:40:21Z
format Article
id doaj.art-a059e0d7de244f1f9c27c741d5d27436
institution Directory Open Access Journal
issn 2831-0896
2831-090X
language English
last_indexed 2024-04-24T23:40:21Z
publishDate 2024-03-01
publisher Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
record_format Article
series Biomolecules & Biomedicine
spelling doaj.art-a059e0d7de244f1f9c27c741d5d274362024-03-15T13:21:04ZengAssociation of Basic Medical Sciences of Federation of Bosnia and HerzegovinaBiomolecules & Biomedicine2831-08962831-090X2024-03-0124210.17305/bb.2023.9775Prognostic significance and immunological role of HPRT1 in human cancersYiwen Lu0Ruixue Chen1Han Zhang2Xu Sun3Xiangjun Li4Mengyuan Yang5Xudong Zhang6Department of Oral and Maxillofacial Surgery, Hebei Key Laboratory of Stomatology, Hebei Clinical Research Center for Oral Diseases, School and Hospital of Stomatology, Hebei Medical University, Shijiazhuang, ChinaDepartment of Oral and Maxillofacial Surgery, Hebei Key Laboratory of Stomatology, Hebei Clinical Research Center for Oral Diseases, School and Hospital of Stomatology, Hebei Medical University, Shijiazhuang, ChinaDepartment of Pathology, Shijiazhuang Great Wall Hospital of Integrated Traditional Chinese and Western Medicine, Shijiazhuang, China Department of Oral and Maxillofacial Surgery, Hebei Key Laboratory of Stomatology, Hebei Clinical Research Center for Oral Diseases, School and Hospital of Stomatology, Hebei Medical University, Shijiazhuang, ChinaDepartment of Oral and Maxillofacial Surgery, Hebei Key Laboratory of Stomatology, Hebei Clinical Research Center for Oral Diseases, School and Hospital of Stomatology, Hebei Medical University, Shijiazhuang, ChinaDepartment of Oral and Maxillofacial Surgery, Hebei Key Laboratory of Stomatology, Hebei Clinical Research Center for Oral Diseases, School and Hospital of Stomatology, Hebei Medical University, Shijiazhuang, ChinaDepartment of Oral and Maxillofacial Surgery, Hebei Key Laboratory of Stomatology, Hebei Clinical Research Center for Oral Diseases, School and Hospital of Stomatology, Hebei Medical University, Shijiazhuang, China Hypoxanthine phosphoribosyl transferase 1 (HPRT1), once considered a housekeeping gene, has been identified as playing an important role in several tumors. Its role in pan-cancer, however, has not been systematically studied. This study evaluates the relationship between HPRT1 and clinical parameters, survival prognosis, and tumor immunity based on multi omics data from the Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) databases. Drug sensitivity analysis screened 16 effective drugs against HPRT1, exploring the interactions with chemicals and genes. The significance of HPRT1 in tumor immunotherapy has also been investigated. Immunohistochemistry confirmed significant differences in the expression of HPRT1 between five tumor types (colon adenocarcinoma [COAD], head-neck squamous cell carcinoma [HNSC], lung adenocarcinoma [LUAD], thyroid carcinoma [THCA], and uterine corpus endometrial carcinoma [UCEC]) and adjacent normal tissues (P < 0.05). HPRT1 competitive endogenous RNA network was constructed in HNSC. Through cytological experiments, it was verified that HPRT1 plays a carcinogenic role in HNSC and is associated with tumor cell proliferation, migration, invasion, and apoptosis. In addition, there was a significant positive correlation between HPRT1 and programmed cell death-1 (PD-1) expression in HNSC (P < 0.05). These findings suggest that HPRT1 may be a potential biomarker for predicting and treating cancer. https://www.bjbms.org/ojs/index.php/bjbms/article/view/9775Pan-cancer, hypoxanthine phosphoribosyl transferase 1 (HPRT1), immunity, cancer risk factors, prognosis
spellingShingle Yiwen Lu
Ruixue Chen
Han Zhang
Xu Sun
Xiangjun Li
Mengyuan Yang
Xudong Zhang
Prognostic significance and immunological role of HPRT1 in human cancers
Biomolecules & Biomedicine
Pan-cancer, hypoxanthine phosphoribosyl transferase 1 (HPRT1), immunity, cancer risk factors, prognosis
title Prognostic significance and immunological role of HPRT1 in human cancers
title_full Prognostic significance and immunological role of HPRT1 in human cancers
title_fullStr Prognostic significance and immunological role of HPRT1 in human cancers
title_full_unstemmed Prognostic significance and immunological role of HPRT1 in human cancers
title_short Prognostic significance and immunological role of HPRT1 in human cancers
title_sort prognostic significance and immunological role of hprt1 in human cancers
topic Pan-cancer, hypoxanthine phosphoribosyl transferase 1 (HPRT1), immunity, cancer risk factors, prognosis
url https://www.bjbms.org/ojs/index.php/bjbms/article/view/9775
work_keys_str_mv AT yiwenlu prognosticsignificanceandimmunologicalroleofhprt1inhumancancers
AT ruixuechen prognosticsignificanceandimmunologicalroleofhprt1inhumancancers
AT hanzhang prognosticsignificanceandimmunologicalroleofhprt1inhumancancers
AT xusun prognosticsignificanceandimmunologicalroleofhprt1inhumancancers
AT xiangjunli prognosticsignificanceandimmunologicalroleofhprt1inhumancancers
AT mengyuanyang prognosticsignificanceandimmunologicalroleofhprt1inhumancancers
AT xudongzhang prognosticsignificanceandimmunologicalroleofhprt1inhumancancers